Evidence map›Paper›PMID 29374810›Full record

ArticleJournal of neuro-oncology2018

Clinical and dosimetric study of radiotherapy for glioblastoma: three-dimensional conformal radiotherapy versus intensity-modulated radiotherapy.

David Thibouw, Gilles Truc, Aurélie Bertaut, Cédric Chevalier, Léone Aubignac, Céline Mirjolet

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David ThibouwDepartment of Radiation Oncology, Georges François Leclerc Cancer Center, Dijon, France.
Gilles TrucDepartment of Radiation Oncology, Georges François Leclerc Cancer Center, Dijon, France. gtruc@cgfl.fr.
Aurélie BertautDepartment of Statistics, Georges François Leclerc Cancer Center, Dijon, France.
Cédric ChevalierDepartment of Radiation Oncology, Georges François Leclerc Cancer Center, Dijon, France.
Léone AubignacDepartment of Medical Physics, Georges François Leclerc Cancer Center, Dijon, France.
Céline MirjoletDepartment of Radiation Oncology, Georges François Leclerc Cancer Center, Dijon, France.ORCID http://orcid.org/0000-0003-0047-9421
Centre Georges François Leclerc · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeWe aimed to compare three-dimensional conformal radiotherapy (3D-CRT) with intensity-modulated radiotherapy (IMRT) for the treatment of glioblastoma. MATERIALS AND

methodsRetrospective study of 220 patients with glioblastoma, treated with 3D-CRT or IMRT, with or without surgery. Dosimetric parameters as well as clinical and survival data for the two techniques were analyzed and compared.

resultsThe median conformity index was 1.53 (range 0-2.69) for 3D-CRT and 1.25 (range 0.97-2.01) for IMRT, p < 10

conclusionIMRT improved target conformity and reduced neurological toxicities for patients with glioblastomas.

Indexed as

Radiotherapy, ConformalRadiotherapy, Intensity-ModulatedAdolescentAdultAgedAged, 80 and overBrain NeoplasmsChildFemaleFollow-Up StudiesGlioblastomaHumansMaleMiddle AgedRadiometryRadiotherapy Dosage3D conformational radiation therapyClinical outcomesDosimetric outcomesGlioblastomaIntensity-modulated radiation therapy

Identifiers

PMID29374810
OpenAlexW2785713790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.